Literature DB >> 19869521

ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI.

W S Tillett1.   

Abstract

1. Rabbits, vaccinated by repeated intravenous injections of suspensions of heat-killed R pneumococci, acquire a marked degree of active immunity to infection with the virulent S forms of Pneumococcus Types I and II. Previously (1) it was shown that the immunization of rabbits with R cells induces active resistance to Type III infection. This immunity is effective when the infecting organisms are injected either intravenously, intraperitoneally, or intradermally. 2. Whole citrated blood or serum of rabbits immunized with R pneumococci, under the experimental conditions described, is capable of passively protecting normal rabbits against Type I and Type III infection. Whole blood appears to be more effective than an equivalent amount of serum. 3. Passive protection of mice by the use of whole blood or serum of the immune rabbits has been entirely ineffectual. This is in striking contrast to the results obtained with type-specific immune serum. 4. This form of acquired resistance to pneumococcus infection, elicited by R organisms which are devoid of type specificity, and exemplified in animals whose sera possess no demonstrable type-specific antibodies, has many characteristics strongly suggesting that the underlying mechanism differs from that concerned in type-specific immunity.

Entities:  

Year:  1928        PMID: 19869521      PMCID: PMC2131512          DOI: 10.1084/jem.48.6.791

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : I. ANTIBODY RESPONSE OF RABBITS IMMUNIZED WITH TYPE III PNEUMOCOCCUS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-03-31       Impact factor: 14.307

2.  EXPERIMENTAL INTRADERMAL PNEUMOCOCCUS INFECTION IN RABBITS.

Authors:  K Goodner
Journal:  J Exp Med       Date:  1928-06-30       Impact factor: 14.307

3.  STUDIES ON EXPERIMENTAL PNEUMONIA : V. ACTIVE IMMUNITY AGAINST EXPERIMENTAL PNEUMOCOCCUS PNEUMONIA IN MONKEYS FOLLOWING VACCINATION WITH LIVING CULTURES OF PNEUMOCOCCUS.

Authors:  R L Cecil; F G Blake
Journal:  J Exp Med       Date:  1920-05-31       Impact factor: 14.307

4.  THE PRODUCTION OF ANTIPNEUMOCOCCIC SERUM.

Authors:  R Cole; H F Moore
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

5.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : III. INCREASED RESISTANCE TO TYPE III INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R AND S FORMS OF PNEUMOCOCCUS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-07-31       Impact factor: 14.307

  5 in total
  10 in total

1.  Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

Authors:  R Malley; M Lipsitch; A Stack; R Saladino; G Fleisher; S Pelton; C Thompson; D Briles; P Anderson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

3.  CERTAIN ASPECTS OF MOUSE PROTECTION TESTS FOR ANTIBODY IN PNEUMOCOCCUS PNEUMONIA.

Authors:  F T Lord; E L Persons
Journal:  J Exp Med       Date:  1931-01-31       Impact factor: 14.307

4.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

5.  STUDIES ON THE DISSOCIATION OF THE HOG CHOLERA BACILLUS : III. ACTIVE IMMUNIZATION WITH R FORMS.

Authors:  C P Li
Journal:  J Exp Med       Date:  1929-11-30       Impact factor: 14.307

6.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

Authors:  L S McDaniel; J Yother; M Vijayakumar; L McGarry; W R Guild; D E Briles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

7.  STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : I. THE CAPACITY OF STRAINS OF PNEUMOCOCCUS TYPE III TO GROW AT 41 degrees C. AND THEIR VIRULENCE FOR RABBITS.

Authors:  J F Enders; M F Shaffer
Journal:  J Exp Med       Date:  1936-06-30       Impact factor: 14.307

8.  Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.

Authors:  L S McDaniel; G Scott; J F Kearney; D E Briles
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

9.  PASSIVE IMMUNITY TO POLIOMYELITIS IN THE CHIMPANZEE.

Authors:  H A Howe; D Bodian
Journal:  J Exp Med       Date:  1945-03-01       Impact factor: 14.307

10.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : II. RESISTANCE TO INFECTION.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.